Evidence map›Paper›PMID 34239390›Full record

ArticleJournal of interventional cardiology2021

Intravascular Lithotripsy for Calcium Modification in Chronic Total Occlusion Percutaneous Coronary Intervention.

Anja Øksnes, Claudia Cosgrove, Simon Walsh, Kjetil Halvorsen Løland, Jack Laffan, Sinjini Biswas, Aadil Shaukat, Colm Hanratty, Julian Strange, James C S Spratt and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of interventional cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The Impact of Calcium on Chronic Total Occlusion Management.Interventional cardiology (London, England) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Anja ØksnesHaukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0003-1997-4449
Claudia CosgroveSt George's University Hospital, London, UK.ORCID https://orcid.org/0000-0003-1754-4680
Simon WalshBelfast Health and Social Care Trust, Belfast, UK.ORCID https://orcid.org/0000-0001-9787-6524
Kjetil Halvorsen LølandHaukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0003-0090-458X
Jack LaffanBelfast Health and Social Care Trust, Belfast, UK.ORCID https://orcid.org/0000-0003-3174-7767
Sinjini BiswasBristol University Hospital, Bristol, UK.ORCID https://orcid.org/0000-0003-1688-9310
Aadil ShaukatGolden Jubilee National Hospital, Glasgow, UK.ORCID https://orcid.org/0000-0001-7409-6859
Colm HanrattyBelfast Health and Social Care Trust, Belfast, UK.ORCID https://orcid.org/0000-0001-5395-4738
Julian StrangeBristol University Hospital, Bristol, UK.ORCID https://orcid.org/0000-0003-0476-0886
James C S SprattSt George's University Hospital, London, UK.ORCID https://orcid.org/0000-0001-8719-4538
Margaret McEntegartGolden Jubilee National Hospital, Glasgow, UK.ORCID https://orcid.org/0000-0001-5135-3322
Belfast Health and Social Care Trust · GBGolden Jubilee National Hospital · GBHaukeland University Hospital · NOSt George's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intravascular lithotripsy (IVL) has been shown to be safe and effective for calcium modification in nonocclusive coronary artery disease (CAD), but there are only case reports of its use in calcified chronic total occlusions (CTO). We report data from an international multicenter registry of IVL use during CTO percutaneous coronary intervention (PCI) and provide provisional data regarding its efficacy and safety. During the study period, IVL was used in 55 of 1053 (5.2%) CTO PCI procedures. IVL was used within the occluded segment after successful CTO crossing in 53 procedures and during incomplete CTO crossing in 2 cases. The mean J-CTO score was 3.1. CTO PCI technical and procedural success was achieved in 53 (96%) and 51 (93%) cases. Six patients had a procedural complication, with 3 main vessel perforations (5%). Two had covered stent implantation, one required pericardiocentesis, and one was managed conservatively. All had combination therapy with another calcium modification device. Two patients had a procedural myocardial infarction (PMI) (4%), and two others had a major adverse cardiovascular event (MACE) (4%) at a median follow-up of 13 (4-21) months. IVL can effectively facilitate calcium modification during CTO PCI. More data are required to establish the efficacy and safety of IVL and other calcium modification devices when used extraplaque or in combination during CTO PCI.

Indexed as

Percutaneous Coronary InterventionAgedCoronary Artery DiseaseCoronary OcclusionFemaleHumansIntraoperative ComplicationsLithotripsyMalePostoperative ComplicationsRegistriesRetrospective StudiesVascular Calcification

Identifiers

PMID34239390
PMCPMC8238593
OpenAlexW3176709918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.